- Exchange: Toronto
- Sector: Consumer, Non-cyclical
- Industry: Biotechnology
- Sub-Industry: Medical-Biomedical/Gene
Amorfix Life Sciences Ltd
+ Add to WatchlistAMF:CN
0.3600 CAD 0.00000.00%As of 15:13:41 ET on 05/21/2013.
Snapshot for Amorfix Life Sciences Ltd (AMF)
| Open: | - | Day's Range: | - | Volume: | 7,800 |
|---|---|---|---|---|---|
| Previous Close: | 0.3600 | 52wk Range: | 0.2500 - 0.6400 | 1-Yr Rtn: | -20.88% |
Key Statistics for AMF
| Current P/E Ratio (ttm) | - |
|---|---|
| Estimated P/E(-) | - |
| Relative P/E vs. SPTSX | - |
| Earnings Per Share (ttm) | -0.0400 |
| Est. EPS | - |
| Est. PEG Ratio | - |
| Market Cap (M CAD) | 21.15 |
| Shares Outstanding (M) | 58.75 |
| 30 Day Average Volume | 13,057 |
| Price/Book (mrq) | 129.5010 |
| Price/Sale (ttm) | 1,107.6331 |
| Dividend Indicated Gross Yield | -% |
| Cash Dividend | - |
| Last Dividend | |
| 5 Year Dividend Growth | - |
| Next Earnings Announcement | 06/13/2013 |
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Income Statement for AMF
Company Profile & Key Executives for AMF
Amorfix Life Sciences Ltd. is a product development company which focuses on therapeutic products and diagnostics targeting misfolded protein diseases including ALS, cancer, and Alzheimer's disease. The Company uses their discovery platform to detect disease specific epitopes on the molecular surface and develops antibodies for diagnostic and clinical evaluation.
| Neil CashmanChairman/Founder | Robert M GundelPresident/CEO |
| Warren WhiteheadChief Financial Officer |
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Sponsored Financial Commentaries
Advertisement
Top Forex Trading Resources
-
AMF News
-
Industry News
No stories found
Advertisement
Advertisement
Sponsored Links
Advertisements
Rate this Page